| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 150,816 | 148,796 | 148,689 | 146,647 | | Cost of Revenue | 50,167 | 47,348 | 47,857 | 48,898 | | | Gross Profit | 100,649 | 101,448 | 100,832 | 97,749 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 49,045 | 51,719 | 56,586 | 59,230 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 30,874 | 31,170 | 30,734 | 30,549 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 20,730 | 18,559 | 13,512 | 7,970 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 49 | 11 | 8 | 1,033 | | Earnings Before Interest And Taxes | 20,779 | 18,570 | 13,520 | 9,003 | | Interest Expense | 13,176 | 13,273 | 12,647 | 17,086 | | Income Before Tax | 7,603 | 5,297 | 873 | (8,083) | | Income Tax Expense | 3,267 | 2,733 | 519 | (3,681) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 4,336 | 2,564 | 354 | (4,402) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 4,336 | 2,564 | 354 | (4,402) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $4,336 | $2,564 | $354 | ($4,402) |
|
1.00% Nasdaq 
Income Statement
